Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Mar;18(3):197-199.
doi: 10.1200/OP.21.00446. Epub 2021 Sep 22.

Renal Cell Carcinoma-Lessons in Diversity, Breakthroughs, and Challenges

Nataliya Mar  1 , Dalia Kaakour  2 , Arash Rezazadeh Kalebasty  1
Affiliations
Comment

Renal Cell Carcinoma-Lessons in Diversity, Breakthroughs, and Challenges

Nataliya Mar et al. JCO Oncol Pract. 2022 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Nataliya MarSpeakers' Bureau: Seattle Genetics Arash Rezazadeh KalebastyStock and Other Ownership Interests: ECOM MedicalConsulting or Advisory Role: Exelixis, AstraZeneca, Bayer, Pfizer, Novartis, Genentech, Bristol Myers Squibb, EMD Serono, Immunomedics, Gilead SciencesSpeakers' Bureau: Janssen, Astellas Medivation, Pfizer, Novartis, Sanofi, Genentech/Roche, Eisai, AstraZeneca, Bristol Myers Squibb, Amgen, Exelixis, EMD Serono, Merck, Seattle Genetics/Astellas, Myovant Sciences, Gilead Sciences, AVEOResearch Funding: Genentech, Exelixis, Janssen, AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Macrogenics, Astellas Pharma, BeyondSpring Pharmaceuticals, BioClin Therapeutics, Clovis Oncology, Bavarian Nordic, Seattle Genetics, Immunomedics, EpizymeTravel, Accommodations, Expenses: Genentech, Prometheus, Astellas Medivation, Janssen, Eisai, Bayer, Pfizer, Novartis, Exelixis, AstraZenecaNo other potential conflicts of interest were reported.

Comment on

Associated data